2026 biocrossroads life sciences summit

Harnessing AI for
Life Sciences Advancement

October 28, 2026 | Hyatt Regency Indianapolis

Perspectives from the 2026 BioCrossroads Life Sciences Summit Speakers

Explore the conversations, research, and practical applications shared at the 2026 BioCrossroads Life Sciences Summit, examining AI’s role in discovery, manufacturing, and patient care.

AI Innovation Hub: Highlighting AI in Action​

Explore the work.
Meet the people behind it.

Research posters and interactive demonstrations connected attendees with researchers, students, startups, and companies exploring AI applications across life sciences. 

in partnership with analytixin

Continue the workshop conversations

data and discovery

Putting Provena Consortium Asset to Work

operational tools

Advancing Healthcare Operations with AI

patient tools

AI-Enabled Tools for Patients

Highlights from the 2026 Summit

Play Video

2026 watanabe award

Recognizing Dr. D. Wade Clapp

BioCrossroads has named Dr. D. Wade Clapp, physician-scientist and interim director of the Indiana University Melvin and Bren Simon Comprehensive Cancer Center, the recipient of the 2026 August M. Watanabe Life Sciences Champion of the Year Award. 

The Bioscience Strength Behind the Conversation

Indiana’s bioscience industry generates more than $125 billion in direct economic impact across human health, animal health, and plant science. BioHeartland brings these connected strengths into a shared story, highlighting the companies, universities, research centers, and innovation districts advancing discovery, production, and delivery.


This year’s Summit explores how AI can build on that foundation through stronger connections among research, industry, and healthcare.

Become a Future Sponsor

The annual Indiana Life Sciences Summit presented by BioCrossroads offers a wide range of sponsorship opportunities. To request a sponsorship prospectus or to discuss a sponsorship level that fits your organization’s needs, please click the button below. 

Introducing Provena Consortium: A New Name for an Established Clinical–Genomic Data Asset Read the Press Release →
+